This small-cap specialty chemicals stock surges 11%, hits 52-week high in trade; check details

Meanwhile, the small-cap stocks were reeling under pressure. The BSE SmallCap index was trading at 45,025.73, down 385.52 points, or 0.85%.

Nevertheless, one of the stocks that defied the selling pressure in the small-cap segment was Camlin Fine Sciences.

The company focuses on four key businesses—shelf life solutions, aroma ingredients, health & wellness, and performance chemicals. Apart from offering antioxidants for the food, pet food, and animal nutrition industries, Camlin Fine Sciences also has a product basket that caters to a wide range of industries.

Camlin Fine Sciences Q3 FY25 Results

For the quarter ended December 31, 2024 (Q3 FY25), Camlin Fine Sciences reported a 12.3% year-on-year (YoY) rise in its consolidated revenue from operations to ₹433.49 crore against ₹385.89 crore registered in the year-ago period.

Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) jumped 163.5% to ₹53.19 crore from ₹32.54 crore registered in the corresponding quarter of the previous fiscal year.

Adjusted EBITDA margins rallied 390 bps to 12.3% during the period under review.

The company's loss narrowed to ₹7.47 crore from ₹14.28 crore in the year-ago quarter.

Operational Revenue Breakup

Total Revenue Break-up

For the December 2024 quarter, Specialty Ingredients (Value Added Blends) contributed 55% of the total revenue, while Specialty Ingredients (Straights) contributed 22% of the company's total revenue. Performance Chemicals's share stood at 10%, while Aroma Ingredients contributed 14% of the total revenue.

Camlin Fine Sciences' stock performance

Camlin Fine Sciences' stock price has rallied 46% in the past six months and 21% in the past year.

The stock hit an all-time high of ₹225.47 on the BSE on July 19, 2021. Its all-time low level stands at ₹1.90, hit on February 24, 2009.